Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway.

Cheng Y, Zhao K, Li G, Yao J, Dai Q, Hui H, Li Z, Guo Q, Lu N.

Anticancer Drugs. 2014 Aug;25(7):778-89. doi: 10.1097/CAD.0000000000000103.

PMID:
24637576
2.

Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.

Wei L, Yao Y, Zhao K, Huang Y, Zhou Y, Zhao L, Guo Q, Lu N.

Mol Carcinog. 2016 Dec;55(12):2121-2134. doi: 10.1002/mc.22456. Epub 2016 Jan 6.

PMID:
26741501
3.

The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro.

Zhou L, Wang DS, Li QJ, Sun W, Zhang Y, Dou KF.

Dig Dis Sci. 2013 Apr;58(4):1016-25. doi: 10.1007/s10620-012-2434-7. Epub 2012 Oct 7.

PMID:
23053901
4.

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Exp Clin Cancer Res. 2013 Sep 5;32:62. doi: 10.1186/1756-9966-32-62.

5.

Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.

Chen TC, Hsu YL, Tsai YC, Chang YW, Kuo PL, Chen YH.

J Mol Med (Berl). 2014 Jan;92(1):53-64. doi: 10.1007/s00109-013-1083-4. Epub 2013 Sep 5.

PMID:
24005829
6.
7.

The Notch1/cyclooxygenase-2/Snail/E-cadherin pathway is associated with hypoxia-induced hepatocellular carcinoma cell invasion and migration.

Yu LX, Zhou L, Li M, Li ZW, Wang DS, Zhang SG.

Oncol Rep. 2013 Jan;29(1):362-70. doi: 10.3892/or.2012.2103. Epub 2012 Oct 23.

PMID:
23124652
8.

Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.

Lu Z, Lu N, Li C, Li F, Zhao K, Lin B, Guo Q.

Toxicol Lett. 2012 Mar 25;209(3):211-20. doi: 10.1016/j.toxlet.2011.12.022. Epub 2012 Jan 10.

PMID:
22245252
9.

Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.

Cannito S, Novo E, Compagnone A, Valfrè di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, Cravanzola C, Bravoco V, Colombatto S, Parola M.

Carcinogenesis. 2008 Dec;29(12):2267-78. doi: 10.1093/carcin/bgn216. Epub 2008 Sep 12.

PMID:
18791199
10.

The effects of shRNA-mediated gene silencing of transcription factor SNAI1 on the biological phenotypes of breast cancer cell line MCF-7.

Lu Y, Yu L, Yang M, Jin X, Liu Z, Zhang X, Wang L, Lin D, Liu Y, Wang M, Quan C.

Mol Cell Biochem. 2014 Mar;388(1-2):113-21. doi: 10.1007/s11010-013-1903-4. Epub 2013 Nov 29.

PMID:
24293287
11.

Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.

Liu T, Liu P, Ding F, Yu N, Li S, Wang S, Zhang X, Sun X, Chen Y, Wang F, Zhao Y, Li B.

Oncol Rep. 2015 Feb;33(2):861-7. doi: 10.3892/or.2014.3672. Epub 2014 Dec 12.

PMID:
25502786
12.

MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.

Chiang KC, Chen SC, Yeh CN, Pang JH, Shen SC, Hsu JT, Liu YY, Chen LW, Kuo SF, Takano M, Kittaka A, Sun CC, Juang HH, Chen TC.

J Steroid Biochem Mol Biol. 2014 Jan;139:54-60. doi: 10.1016/j.jsbmb.2013.10.005. Epub 2013 Oct 12.

PMID:
24125734
13.

JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.

Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.

Int J Oncol. 2014 May;44(5):1643-51. doi: 10.3892/ijo.2014.2310. Epub 2014 Feb 21.

PMID:
24573038
14.

Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.

Li X, Miao H, Zhang Y, Li W, Li Z, Zhou Y, Zhao L, Guo Q.

Arch Toxicol. 2015 Jan;89(1):121-36. doi: 10.1007/s00204-014-1226-6. Epub 2014 Mar 27.

PMID:
24671465
15.

Celastrol inhibits TGF-β1-induced epithelial-mesenchymal transition by inhibiting Snail and regulating E-cadherin expression.

Kang H, Lee M, Jang SW.

Biochem Biophys Res Commun. 2013 Aug 9;437(4):550-6. doi: 10.1016/j.bbrc.2013.06.113. Epub 2013 Jul 10.

PMID:
23850675
16.

Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.

Lundgren K, Nordenskjöld B, Landberg G.

Br J Cancer. 2009 Nov 17;101(10):1769-81. doi: 10.1038/sj.bjc.6605369. Epub 2009 Oct 20.

17.

Notch activation stimulates migration of breast cancer cells and promotes tumor growth.

Bolós V, Mira E, Martínez-Poveda B, Luxán G, Cañamero M, Martínez-A C, Mañes S, de la Pompa JL.

Breast Cancer Res. 2013;15(4):R54.

18.
19.

Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs.

Sun DW, Zhang HD, Mao L, Mao CF, Chen W, Cui M, Ma R, Cao HX, Jing CW, Wang Z, Wu JZ, Tang JH.

Cell Physiol Biochem. 2015;37(5):1693-711. doi: 10.1159/000438535. Epub 2015 Nov 9.

20.

Supplemental Content

Support Center